First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.

<h4>Background</h4>Tuberculosis (TB) is one of the major public health problems in Congo. However, data concerning Mycobacterium tuberculosis drug resistance are lacking because of the insufficient processing capacity. So, the aim of this study was to investigate for the first time the r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexandra Aubry, Wladimir Sougakoff, Pamela Bodzongo, Guy Delcroix, Sylvie Armand, Gérald Millot, Vincent Jarlier, René Courcol, Nadine Lemaître
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/45e8c7106ea34fbbbe055b263c58756b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:45e8c7106ea34fbbbe055b263c58756b
record_format dspace
spelling oai:doaj.org-article:45e8c7106ea34fbbbe055b263c58756b2021-11-18T08:22:36ZFirst evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.1932-620310.1371/journal.pone.0095083https://doaj.org/article/45e8c7106ea34fbbbe055b263c58756b2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24743770/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Tuberculosis (TB) is one of the major public health problems in Congo. However, data concerning Mycobacterium tuberculosis drug resistance are lacking because of the insufficient processing capacity. So, the aim of this study was to investigate for the first time the resistance patterns and the strain lineages of a sample of M. tuberculosis complex (MTBC) isolates collected in the two main cities of Congo.<h4>Methods</h4>Over a 9-day period, 114 smear-positive sputa isolated from 114 patients attending centers for the diagnosis and treatment of TB in Brazzaville and Pointe Noire were collected for culture and drug susceptibility testing (DST). Detection of mutations conferring drug resistance was performed by using line probe assays (GenoType MTBDRplus and MTBDRsl) and DNA sequencing. Strain lineages were determined by MIRU-VNTR genotyping.<h4>Results</h4>Of the 114 sputa, 46 were culture positive for MTBC. Twenty-one (46%) were resistant to one or more first-line antiTB drugs. Of these, 15 (71%) were multidrug resistant (MDR). The most prevalent mutations involved in rifampin and isoniazid resistance, D516V (60%) in rpoB and S315T (87%) in katG respectively, were well detected by MTBDRplus assay. All the 15 MDR strains were susceptible to fluoroquinolone and injectable second-line drug. No mutation was detected in the rrs locus involved in resistance to amikacin and capreomycin by both the MTBDRsl assay and DNA sequencing. By contrast, 9 MDR strains belonging to the same cluster related to T-family were identified as being falsely resistant to fluoroquinolone by the MTBDRsl assay due to the presence of a double substitution T80A-A90G in GyrA.<h4>Conclusions</h4>Taken together, these data revealed a possible spread of a particular MDR clone in Congo, misidentified as fluoroquinolone resistant by MTBDRsl assay. Thus, this test cannot replace gold-standard culture method and should be interpreted carefully in view of the patient's native land.Alexandra AubryWladimir SougakoffPamela BodzongoGuy DelcroixSylvie ArmandGérald MillotVincent JarlierRené CourcolNadine LemaîtrePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 4, p e95083 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alexandra Aubry
Wladimir Sougakoff
Pamela Bodzongo
Guy Delcroix
Sylvie Armand
Gérald Millot
Vincent Jarlier
René Courcol
Nadine Lemaître
First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
description <h4>Background</h4>Tuberculosis (TB) is one of the major public health problems in Congo. However, data concerning Mycobacterium tuberculosis drug resistance are lacking because of the insufficient processing capacity. So, the aim of this study was to investigate for the first time the resistance patterns and the strain lineages of a sample of M. tuberculosis complex (MTBC) isolates collected in the two main cities of Congo.<h4>Methods</h4>Over a 9-day period, 114 smear-positive sputa isolated from 114 patients attending centers for the diagnosis and treatment of TB in Brazzaville and Pointe Noire were collected for culture and drug susceptibility testing (DST). Detection of mutations conferring drug resistance was performed by using line probe assays (GenoType MTBDRplus and MTBDRsl) and DNA sequencing. Strain lineages were determined by MIRU-VNTR genotyping.<h4>Results</h4>Of the 114 sputa, 46 were culture positive for MTBC. Twenty-one (46%) were resistant to one or more first-line antiTB drugs. Of these, 15 (71%) were multidrug resistant (MDR). The most prevalent mutations involved in rifampin and isoniazid resistance, D516V (60%) in rpoB and S315T (87%) in katG respectively, were well detected by MTBDRplus assay. All the 15 MDR strains were susceptible to fluoroquinolone and injectable second-line drug. No mutation was detected in the rrs locus involved in resistance to amikacin and capreomycin by both the MTBDRsl assay and DNA sequencing. By contrast, 9 MDR strains belonging to the same cluster related to T-family were identified as being falsely resistant to fluoroquinolone by the MTBDRsl assay due to the presence of a double substitution T80A-A90G in GyrA.<h4>Conclusions</h4>Taken together, these data revealed a possible spread of a particular MDR clone in Congo, misidentified as fluoroquinolone resistant by MTBDRsl assay. Thus, this test cannot replace gold-standard culture method and should be interpreted carefully in view of the patient's native land.
format article
author Alexandra Aubry
Wladimir Sougakoff
Pamela Bodzongo
Guy Delcroix
Sylvie Armand
Gérald Millot
Vincent Jarlier
René Courcol
Nadine Lemaître
author_facet Alexandra Aubry
Wladimir Sougakoff
Pamela Bodzongo
Guy Delcroix
Sylvie Armand
Gérald Millot
Vincent Jarlier
René Courcol
Nadine Lemaître
author_sort Alexandra Aubry
title First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
title_short First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
title_full First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
title_fullStr First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
title_full_unstemmed First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
title_sort first evaluation of drug-resistant mycobacterium tuberculosis clinical isolates from congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution t80a-a90g in gyra.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/45e8c7106ea34fbbbe055b263c58756b
work_keys_str_mv AT alexandraaubry firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT wladimirsougakoff firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT pamelabodzongo firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT guydelcroix firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT sylviearmand firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT geraldmillot firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT vincentjarlier firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT renecourcol firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
AT nadinelemaitre firstevaluationofdrugresistantmycobacteriumtuberculosisclinicalisolatesfromcongorevealedmisdetectionoffluoroquinoloneresistancebylineprobeassayduetoadoublesubstitutiont80aa90gingyra
_version_ 1718421857254768640